Patanjali stopped the sale of many products, the company told the Supreme Court, know the full update
New Delhi: Patanjali Ayurveda Limited, run by Baba Ramdev, submitted an affidavit in the Supreme Court on Tuesday and informed that it has banned the sale of 14 products and instructions have been given to withdraw their advertisements. In fact, the Supreme Court had reprimanded Baba Ramdev and Patanjali Ayurveda MD Acharya Balkrishna for the misleading publicity done by the company regarding these products. After which he had to apologize publicly. These are the products which were launched in the market by Patanjali during the Corona period and it was claimed that these can cure corona disease completely. The manufacturing licenses of these products were suspended by the Uttarakhand State Licensing Authority in April 2024.
In April this year, the Drug Regulator of Uttarakhand had banned 14 products made by Ramdev’s pharmaceutical company. This action was taken due to the company repeatedly publishing misleading advertisements about the drug. The licensing authority of Uttarakhand suspended the license of 14 products made by Patanjali’s Divya Pharmacy for repeatedly publishing misleading advertisements about their effectiveness. Earlier, Ramdev had to apologize in the Supreme Court regarding the misleading advertisement related to his medicine.
Patanjali informed in writing before the Supreme Court on Tuesday that it has also stopped the sale of its 14 products, which were suspended by the drug regulator of Uttarakhand. These products also include Ramdev’s traditional medicines for asthma, bronchitis and diabetes. According to media reports, the medicines of Divya Pharmacy on which the government has banned include Shwasari Gold, Shwasari Vati, Broncom, Shwasari Pravahi, Shwasari Avaleha, Mukta Vati Extra Power, Lipidom, Livamrit Advance, Livogrit, BP Grit, Madhugrit, Madhunashini Vati Extra Power and Patanjali Drishti Eye Drops.
The Supreme Court is hearing the misleading advertisement by Patanjali regarding the medicine and the court has scheduled the next hearing in the case on July 30. Earlier, the Supreme Court had reprimanded Baba Ramdev and Acharya Balkrishna for misleading advertisement of the medicine and asked them to apologize. On April 23, it was reprimanded again for not prominently displaying its apology in newspapers. The Supreme Court had till now questioned Baba Ramdev whether the size of the apology given by Patanjali in newspapers was the same as the full page for its products? Patanjali then informed that it has published the apology in 67 newspapers and will not repeat its mistake.
The apex court is hearing a petition filed by the Indian Medical Association (IMA), in which Patanjali has been accused of running a propaganda campaign against the Kovid vaccination campaign and modern medical systems.
